Decision maker in a preclinical CRO, you know that synergizing with the right complementary CROs can make a big difference when it comes to rapidly fulfilling your clients’ project needs. You are aware that building on mutual experiences and learning from each other maximizes each partner’s reactivity and efficiency, and also enhances each one’s capability for convincing new clients. You think that building trustful partnerships is far better than working in isolation… At Drugabilis, we think the same. Experts in pharmaceutical drugability for research, we are open to building long-term partnerships with complementary preclinical friendly CROs, with a special emphasis on pharmacology, pharmacokinetics, toxicology, medicinal chemistry, process chemistry and pharmaceutical development.
Understand where we could find synergies >
Latest news
2024 AFSSI Connexions
Back to the images of the 2024 AFSSI Connexions in Montpellier (2nd and 3rd of July)... Like last...
more news>
useful ressources
job offers/application
contact us